विधियों की तुलना करें
चुनी हुई विधियों की आमने-सामने समीक्षा करें; भिन्नता वाली पंक्तियाँ रेखांकित हैं।
| CONSORT चेकलिस्ट: यादृच्छिक नियंत्रित परीक्षणों की रिपोर्टिंग के लिए मानक× | रैंडमाइज्ड कंट्रोल्ड ट्रायल्स के लिए कोचरन रिस्क ऑफ बायस टूल 2.0× | |
|---|---|---|
| क्षेत्र | अनुसंधान पद्धति | अनुसंधान पद्धति |
| परिवार | Process / pipeline | Process / pipeline |
| उद्भव वर्ष≠ | 2010 (original 1996) | 2019 |
| प्रवर्तक≠ | Schulz et al. (CONSORT Group) | Jonathan Sterne, Julian Higgins (Cochrane Collaboration) |
| प्रकार≠ | Trial author reporting checklist | Clinician-rated / Research team assessment |
| मौलिक स्रोत≠ | Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. The Lancet, 375(9721), 1657–1668. DOI ↗ | Sterne, J. A., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., ... & Higgins, J. P. (2019). RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ, 366, l4898. DOI ↗ |
| उपनाम | CONSORT, CONSORT 2010 | RoB 2.0, RoB 2 |
| संबंधित | 4 | 4 |
| सारांश≠ | The CONSORT (Consolidated Standards of Reporting Trials) Statement is a 25-item evidence-based checklist and flow diagram developed to standardize reporting of parallel-group randomized controlled trials. First published in 1996 and updated in 2010 (CONSORT 2010), it is endorsed by over 600 journals including The Lancet, JAMA, and BMJ, and is mandatory or strongly recommended for RCT manuscript submission across clinical research. | RoB 2 is the Cochrane Collaboration's updated methodology for assessing the risk of bias in randomized controlled trials (RCTs). Published in 2019, it replaced the original Cochrane RoB tool with a more structured, transparent approach using signalling questions and domain-based judgments to evaluate five critical sources of bias. |
| ScholarGateडेटासेट ↗ |
|
|